CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $192,034 | -23.8% | 292,645 | 0.0% | 0.02% | -29.2% |
| Q3 2022 | $252,000 | +56.5% | 292,645 | 0.0% | 0.02% | +60.0% |
| Q2 2022 | $161,000 | -50.5% | 292,645 | 0.0% | 0.02% | -46.4% |
| Q1 2022 | $325,000 | -4.7% | 292,645 | +47.7% | 0.03% | -28.2% |
| Q4 2021 | $341,000 | -43.9% | 198,106 | 0.0% | 0.04% | -35.0% |
| Q3 2021 | $608,000 | -21.3% | 198,106 | 0.0% | 0.06% | -25.9% |
| Q2 2021 | $773,000 | +39.8% | 198,106 | 0.0% | 0.08% | +26.6% |
| Q1 2021 | $553,000 | -8.7% | 198,106 | 0.0% | 0.06% | -16.9% |
| Q4 2020 | $606,000 | -49.7% | 198,106 | 0.0% | 0.08% | -57.9% |
| Q3 2020 | $1,204,000 | +2.8% | 198,106 | 0.0% | 0.18% | -9.9% |
| Q2 2020 | $1,171,000 | +123.0% | 198,106 | 0.0% | 0.20% | +72.0% |
| Q1 2020 | $525,000 | -2.6% | 198,106 | 0.0% | 0.12% | +15.7% |
| Q4 2019 | $539,000 | +1397.2% | 198,106 | +6503.5% | 0.10% | +1175.0% |
| Q3 2019 | $36,000 | +5.9% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $34,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |